Ethyl dirazepate
From Wikipedia, the free encyclopedia
Chemical compound
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C18H14Cl2N2O3 |
Molar mass | 377.22 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Ethyl dirazepate[1] is a drug which is a benzodiazepine derivative which was developed by Sanofi Winthrop. It has anxiolytic and hypnotic and possibly other characteristic benzodiazepine properties.[2][3][4]
See also[edit]
References[edit]
- ^ ZA Patent 6804601
- ^ "ethyl dirazepate". psychotropics.dk. 2003. Retrieved 7 December 2009.
- ^ "Drugs of the Future". Thomson Reuters. 6 (11). November 1981.
- ^ "LIST OF INTERNATIONAL NON-PROPRIETARY NAMES (INNS), PROVIDED FOR PHARMACEUTICAL SUBSTANCES BY THE WORLD HEALTH ORGANIZATION, WHICH ARE FREE OF DUTY". Official Journal of the European Communities. eur-lex.europa.eu. 23 October 2001. Archived from the original (PDF) on 27 June 2014. Retrieved 7 December 2009.
Hidden categories:
- Articles with short description
- Short description matches Wikidata
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- Articles with changed InChI identifier
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs missing an ATC code
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- All stub articles